We are live on ! Find out more
Commonwealth Equity Services

Commonwealth Equity Services Portfolio holdings

AUM $71.6B
1-Year Est. Return 21.08%
This Fund
S&P 500
This Quarter Est. Return
+7.31%
1 Year Est. Return
+21.08%
3 Year Est. Return
+64.42%
5 Year Est. Return
+73.55%
10 Year Est. Return
+239.11%
AUM
$26.3B
AUM Growth
+$2.84B
Cap. Flow
+$1.22B
Cap. Flow %
4.63%
Top 10 Hldgs %
17.1%
Holding
3,009
New
172
Increased
1,653
Reduced
960
Closed
126

Sector Composition

Rank Sector Weight
1 Technology 8.1%
2 Financials 6.17%
3 Healthcare 4.86%
4 Communication Services 3.82%
5 Consumer Discretionary 3.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YELL
2801
DELISTED
Yellow Corporation Common Stock
YELL
$43K ﹤0.01%
17,151
+5,950
+53% +$20.4K
CIF
2802
DELISTED
MFS Intermediate High Income Fund
CIF
$42K ﹤0.01%
15,093
KALA icon
2803
KALA BIO
KALA
$11.8M
$42K ﹤0.01%
5
+1
+25% +$9.66K
UEC icon
2804
Uranium Energy
UEC
$4.71B
$42K ﹤0.01%
46,500
SMTX
2805
DELISTED
SMTC Corporation
SMTX
$42K ﹤0.01%
12,660
AGEN
2806
Agenus
AGEN
$249M
$41K ﹤0.01%
516
-20
-4% -$1.34K
VRML
2807
DELISTED
Vermillion, Inc.
VRML
$41K ﹤0.01%
+51,784
New +$34.1K
CYH icon
2808
Community Health Systems
CYH
$385M
$40K ﹤0.01%
13,911
-528
-4% -$1.83K
MTNB icon
2809
Matinas BioPharma
MTNB
$1.55M
$40K ﹤0.01%
360
+20
+6% +$1.16K
USAU icon
2810
US Gold Corp
USAU
$220M
$40K ﹤0.01%
5,000
+800
+19% +$6.54K
VSTM icon
2811
Verastem
VSTM
$532M
$40K ﹤0.01%
2,541
-17
-0.7% -$244
AVGR
2812
DELISTED
Avinger, Inc. Common Stock
AVGR
$38K ﹤0.01%
+112
New +$39.1K
ACGN
2813
DELISTED
Aceragen Inc
ACGN
$38K ﹤0.01%
1,233
IAG icon
2814
IAMGOLD
IAG
$8.47B
$37K ﹤0.01%
+10,010
New +$35.4K
BLCM
2815
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$36K ﹤0.01%
2,868
-30
-1% -$277
NBEV
2816
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$36K ﹤0.01%
20,116
-1,978
-9% -$4.68K
TEUM
2817
DELISTED
Pareteum Corporation
TEUM
$36K ﹤0.01%
83,531
+5,725
+7% +$3.31K
BGFV
2818
DELISTED
Big 5 Sporting Goods
BGFV
$35K ﹤0.01%
11,841
+17
+0.1% +$46
PRPH
2819
DELISTED
ProPhase Labs
PRPH
$35K ﹤0.01%
1,794
+166
+10% +$3.25K
XXII
2820
22nd Century Group
XXII
$1.47M
0
SRNE
2821
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$35K ﹤0.01%
10,420
-6,526
-39% -$15.6K
GCVRZ
2822
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$35K ﹤0.01%
41,260
+24,580
+147% +$18.9K
AQB icon
2823
AquaBounty Technologies
AQB
$4.68M
$34K ﹤0.01%
+798
New +$35.9K
RBBN icon
2824
Ribbon Communications
RBBN
$354M
$34K ﹤0.01%
+11,164
New +$44.4K
VIVS
2825
VivoSim Labs
VIVS
$1.46M
$33K ﹤0.01%
395
+7
+2% +$655

Similar funds

Commonwealth Equity Services's Q4 2019 Portfolio in Review

As of Q4 2019, Commonwealth Equity Services held 3,009 positions worth $26.3B, up 12% from $23.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Commonwealth Equity Services deployed $1.22B of net new capital in Q4 2019, opening 172 new positions and adding to 1,653 existing holdings. Its largest new stake was Innovator US Equity Power Buffer ETF December: 815,338 shares worth $21.8M.

By sector, the portfolio is most concentrated in Technology at 8.1% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares 10-20 Year Treasury Bond ETF, an estimated $20.5M trimmed.

  • Commonwealth Equity Services's largest Q4 2019 buy was Innovator US Equity Power Buffer ETF December: 815,338 shares worth $21.8M.
  • Commonwealth Equity Services added most to iShares Core S&P 500 ETF in Q4 2019, an estimated $48.6M increase.
  • Commonwealth Equity Services's biggest Q4 2019 reduction was iShares 10-20 Year Treasury Bond ETF, cutting an estimated $20.5M.
  • Commonwealth Equity Services fully exited Celgene Corp in Q4 2019, selling an estimated $13.7M.
  • Commonwealth Equity Services's ten largest holdings make up 17% of its $26.3B portfolio in Q4 2019.
  • Commonwealth Equity Services opened 172 new positions and closed 126 in Q4 2019.
  • Commonwealth Equity Services's portfolio value rose 12% quarter-over-quarter to $26.3B.

Based on Commonwealth Equity Services's 13F filing for Q4 2019, filed 5 Feb 2020.